{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Defending Against Nonperformance Of Life Science Contracts",
    "url": "https://www.lexblog.com/2020/04/21/force-majeure-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-S5APW271",
        "url": "https://www.lexblog.com/lib/S5APW271/"
    },
    "datePublished": "2020-04-21T19:30:05-04:00",
    "dateModified": "2023-03-21T15:21:38-04:00",
    "author": {
        "@type": "Person",
        "name": "Bradley Graveline, Evan Sumner"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Intellectual Property Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.intellectualpropertylawblog.com/?p=2981",
    "sourceStability": "may-move"
}